Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium

Citation
Rv. Shohet et al., Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium, CIRCULATION, 101(22), 2000, pp. 2554-2556
Citations number
21
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
101
Issue
22
Year of publication
2000
Pages
2554 - 2556
Database
ISI
SICI code
0009-7322(20000606)101:22<2554:EDOAMD>2.0.ZU;2-S
Abstract
Background-The noninvasive, tissue-specific delivery of therapeutic agents to the heart would be a valuable clinical tool. This study addressed the hy pothesis that albumin-coated microbubbles could be used to effectively deli ver an adenoviral transgene to rat myocardium by ultrasound-mediated microb ubble destruction, Methods and Results-Recombinant adenovirus containing beta-galactosidase an d driven by a constitutive promoter was attached to the surface of albumin- coated, perfluoropropane-filled microbubbles, These bubbles were infused in to the jugular vein of rats with or without simultaneous echocardiography. Additional controls included ultrasound of microbubbles that did not contai n virus, virus alone, and virus plus ultrasound. One group underwent ultras ound-mediated destruction of microbubbles followed by adenovirus infusion. Rats were killed after 4 days and examined for beta-galactosidase expressio n. The hearts of all rats that underwent ultrasound-mediated destruction of microbubbles containing virus showed nuclear staining with 5-bromo-4-chlor o-3-indolyl-beta-D-galactopyranoside substrate, indicating expression of th e transgene. None of the control animals showed myocardial expression of th e beta-galactosidase transgene. By quantitative analysis, beta-galactosidas e activity was 10-fold higher in the treated group than in controls (P<0.00 01). Conclusions-Ultrasound-mediated destruction of albumin-coated microbubbles is a promising method for the delivery of bioactive agents to the heart.